Cargando…
Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach
Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell line...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608695/ https://www.ncbi.nlm.nih.gov/pubmed/23555699 http://dx.doi.org/10.1371/journal.pone.0059536 |
_version_ | 1782264270646411264 |
---|---|
author | Jäger, Wolfgang Moskalev, Igor Janssen, Claudia Hayashi, Tetsutaro Awrey, Shannon Gust, Kilian M. So, Alan I. Zhang, Kaixin Fazli, Ladan Li, Estelle Thüroff, Joachim W. Lange, Dirk Black, Peter C. |
author_facet | Jäger, Wolfgang Moskalev, Igor Janssen, Claudia Hayashi, Tetsutaro Awrey, Shannon Gust, Kilian M. So, Alan I. Zhang, Kaixin Fazli, Ladan Li, Estelle Thüroff, Joachim W. Lange, Dirk Black, Peter C. |
author_sort | Jäger, Wolfgang |
collection | PubMed |
description | Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected between the muscle wall and the mucosa to separate these layers, and tumor cells were subsequently injected into this space. Bioluminescence and ultrasound were used to monitor tumor growth. Contrast-enhanced ultrasound was used to study changes in tumor perfusion after systemic gemcitabine/cisplatin treatment. To demonstrate proof of principle that therapeutic agents can be injected into established xenografts under ultrasound guidance, oncolytic virus (VSV) was injected into UM-UC3 tumors. Xenograft tissue was harvested for immunohistochemistry after 23–37 days. Percutaneous injection of tumor cells into the bladder wall was performed efficiently (mean time: 5.7 min) and without complications in all 50 animals. Ultrasound and bioluminescence confirmed presence of tumor in the anterior bladder wall in all animals 3 days later. The average tumor volumes increased steadily over the study period. UM-UC13 tumors showed a marked decrease in volume and perfusion after chemotherapy. Immunohistochemical staining for VSV-G demonstrated virus uptake in all UM-UC3 tumors after intratumoral injection. We have developed a novel method for creating orthotopic bladder cancer xenograft in a minimally invasive fashion. In our hands this has replaced the traditional model requiring laparotomy, because this model is more time efficient, more precise and associated with less morbidity for the mice. |
format | Online Article Text |
id | pubmed-3608695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36086952013-04-03 Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach Jäger, Wolfgang Moskalev, Igor Janssen, Claudia Hayashi, Tetsutaro Awrey, Shannon Gust, Kilian M. So, Alan I. Zhang, Kaixin Fazli, Ladan Li, Estelle Thüroff, Joachim W. Lange, Dirk Black, Peter C. PLoS One Research Article Orthotopic bladder cancer xenografts are essential for testing novel therapies and molecular manipulations of cell lines in vivo. Current xenografts rely on tumor cell inoculation by intravesical instillation or direct injection into the bladder wall. Instillation is limited by the lack of cell lines that are tumorigenic when delivered in this manner. The invasive model inflicts morbidity on the mice by the need for laparotomy and mobilization of the bladder. Furthermore this procedure is complex and time-consuming. Three bladder cancer cell lines (UM-UC1, UM-UC3, UM-UC13) were inoculated into 50 athymic nude mice by percutaneous injection under ultrasound guidance. PBS was first injected between the muscle wall and the mucosa to separate these layers, and tumor cells were subsequently injected into this space. Bioluminescence and ultrasound were used to monitor tumor growth. Contrast-enhanced ultrasound was used to study changes in tumor perfusion after systemic gemcitabine/cisplatin treatment. To demonstrate proof of principle that therapeutic agents can be injected into established xenografts under ultrasound guidance, oncolytic virus (VSV) was injected into UM-UC3 tumors. Xenograft tissue was harvested for immunohistochemistry after 23–37 days. Percutaneous injection of tumor cells into the bladder wall was performed efficiently (mean time: 5.7 min) and without complications in all 50 animals. Ultrasound and bioluminescence confirmed presence of tumor in the anterior bladder wall in all animals 3 days later. The average tumor volumes increased steadily over the study period. UM-UC13 tumors showed a marked decrease in volume and perfusion after chemotherapy. Immunohistochemical staining for VSV-G demonstrated virus uptake in all UM-UC3 tumors after intratumoral injection. We have developed a novel method for creating orthotopic bladder cancer xenograft in a minimally invasive fashion. In our hands this has replaced the traditional model requiring laparotomy, because this model is more time efficient, more precise and associated with less morbidity for the mice. Public Library of Science 2013-03-26 /pmc/articles/PMC3608695/ /pubmed/23555699 http://dx.doi.org/10.1371/journal.pone.0059536 Text en © 2013 Jäger et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Jäger, Wolfgang Moskalev, Igor Janssen, Claudia Hayashi, Tetsutaro Awrey, Shannon Gust, Kilian M. So, Alan I. Zhang, Kaixin Fazli, Ladan Li, Estelle Thüroff, Joachim W. Lange, Dirk Black, Peter C. Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach |
title | Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach |
title_full | Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach |
title_fullStr | Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach |
title_full_unstemmed | Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach |
title_short | Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach |
title_sort | ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608695/ https://www.ncbi.nlm.nih.gov/pubmed/23555699 http://dx.doi.org/10.1371/journal.pone.0059536 |
work_keys_str_mv | AT jagerwolfgang ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT moskalevigor ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT janssenclaudia ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT hayashitetsutaro ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT awreyshannon ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT gustkilianm ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT soalani ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT zhangkaixin ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT fazliladan ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT liestelle ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT thuroffjoachimw ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT langedirk ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach AT blackpeterc ultrasoundguidedintramuralinoculationoforthotopicbladdercancerxenograftsanovelhighprecisionapproach |